FALESSA- folic acid tablet
Avion Pharmaceuticals, LLC
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
----------
FaLessa™ with Quatrefolic®, Fourth Generation folate is a round, light blue tablet imprinted with a Q.
Folate 1 mg (as 1.85 mg Quatrefolic® ((6S)-5,-methyltetrahydrofolate glucosamine salt* CAS 1181972-37-1) molar equivalent to 1 mg of Folic acid)
Croscarmellose Sodium, Dicalcium Phosphate, FD&C Blue #1, FD&C Blue #2, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Titanium Dioxide, Triacetin.
FaLessa™ folate tablets are a folic acid supplement indicated to be beneficial in improving the nutritional status of women prior to conception and throughout pregnancy.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients contained herein.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
FALESSA
folic acid tablet |
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
||||||||||||||||||||||||
|
Labeler - Avion Pharmaceuticals, LLC (965450542) |